A Closer Look at 9 Analyst Recommendations For CG Oncology
A Closer Look at 9 Analyst Recommendations For CG Oncology
对CG Oncology进行的九项分析师建议的详细评估
9 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a diverse set of opinions from bullish to bearish.
过去季度，有9位分析师分别对CG Oncology（NASDAQ：CGON）提出了各种观点，从看好到看淡提供了多样化的意见。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts have recently evaluated CG Oncology and provided 12-month price targets. The average target is $68.33, accompanied by a high estimate of $75.00 and a low estimate of $50.00. This current average has decreased by 1.92% from the previous average price target of $69.67.
分析师最近对CG Oncology进行了评估，提出了12个月的价格目标。平均目标为$68.33，高估为$75.00，低估为$50.00。这个当前平均值比之前的平均目标价$69.67下降了1.92%。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
In examining recent...
通过审...
登录免费看全文
登录/注册